PARIS, France—After TAVR, patients prescribed single antiplatelet therapy are less likely to report a major adverse event at 3 months than those on dual antiplatelet therapy, according to results of ...

Dental extraction is performed frequently and can be accompanied by perioperative or postoperative complications. Bleeding is among the most common and important issues to consider in the ...

In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.

Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

MILAN — Despite expectations that restarting aspirin or clopidogrel (Plavix, Sanofi-Aventis) following an intracranial hemorrhage (ICH)–associated stroke might increase risk for a recurrent brain ...

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...

Please provide your email address to receive an email when new articles are posted on . Single antiplatelet therapy was tied to lower 6-month mortality risk vs. dual antiplatelet therapy after ...

Antiplatelet therapy is a key component in the management of many medical diseases to decrease the risk of cardiovascular events.1 Acetylsalicyclic acid (ASA) is the most common antiplatelet agent ...

Although seemingly inappropriate, antiplatelet therapy could benefit patients who have survived intracerebral hemorrhage (ICH) and are therefore at risk of recurrent ICH. The decision to prescribe ...

There was no benefit to modulating the intensity of antiplatelet therapy compared with standard antiplatelet therapy in high-risk patients who had undergone complex stenting procedures, according to ...